Protagonist Therapeutics, Inc. (PTGX)
91.41
-3.42
(-3.61%)
USD |
NASDAQ |
Mar 05, 16:00
90.50
-0.91
(-1.00%)
Pre-Market: 08:47
Protagonist Therapeutics Cash from Investing (TTM) : -49.33M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| ADMA Biologics, Inc. | -21.89M |
| Glaukos Corp. | -77.61M |
| Krystal Biotech, Inc. | -58.42M |
| Olema Pharmaceuticals, Inc. | -108.00M |